Content
All Posts > Content under Healthcare
Better Healthcare Dividend Stock: Abbott Labs Or AbbVie?
Article By:
SureDividend
Read
Tuesday, January 31, 2017 11:52 AM EDT
AbbVie and Abbott are both high-quality businesses. They both have strong brands in their respective categories and leadership positions in their core industries.
Thermo Fisher (TMO): Tops Q4 Earnings, Misses Revenues
Article By:
Zacks Investment Research
Read
Tuesday, January 31, 2017 10:23 AM EDT
Thermo Fisher posted revenues of $4,953.2 billion, including $1.34 billion (up 10%) in Life Sciences Solutions, and $1.22 billion (up 32%) in Analytical Instruments.
In this article: TMO
Pfizer Inc. Shares Fall On Earnings Miss, Eli Lilly And Co. Little Changed On Sales Beat
Aetna (AET) Beats Q4 Earnings Estimates, Guides For 2017
Article By:
Zacks Investment Research
Read
Tuesday, January 31, 2017 8:46 AM EDT
Aetna beat on earnings but revenues missed expectations. AET posted operating revenues of $15.72 billion, a tad lower than consensus estimate of $15.9 billion, but grew 5% year over year.
Interview With Vitality Biopharma Inc.
Article By:
InvestInMJ
Read
Monday, January 30, 2017 3:00 PM EDT
We recently had the pleasure to speak to Robert Brooke, the CEO of Vitality Biopharma, a publicly traded pharmaceutical company focused on cannabis based medical drugs, and their recent R&D breakthrough for those suffering from IBD & Crohn's Disease.
Biotech Blahs Worsened By Political Distractions
Article By:
Rod Raynovich
Read
Monday, January 30, 2017 2:14 PM EDT
It is getting harder to find trades and identify long term investments in healthcare and biotechnology. While we are still in a trading range since the election, we are unable to get traction on the upside.
Emergent BioSolutions Get Approval For New Construction Site In Germany
Article By:
KKD Healthcare Analytics
Read
Monday, January 30, 2017 12:50 PM EDT
Emergent BioSolutions announced receiving approval from German Federal Ministry of Health for the construction of Building 55. The building will be used for manufacturing BioThrax.
In this article: EBS
Drug Stocks Reporting Q4 Earnings On Jan 31: LLY And PFE
Article By:
Zacks Investment Research
Read
Monday, January 30, 2017 9:46 AM EDT
Eli Lilly’s bottom-line performance has been mixed so far, with its earnings surpassing expectations in two of the last four quarters, and missing the same in the other two, bringing the average negative surprise to 2.05%.
My Investing Missteps And Blunders
Article By:
Keith Park
Read
Sunday, January 29, 2017 7:21 PM EDT
Sometimes it’s just better to buy into the boring slow growth, steady dividend payers and hold them over the long haul rather than risk significant funds on unproven technologies or ultra cheap stocks.
Drug Prices In The US Vs. Canada - The Big Pharma Political Connection
Article By:
Jesse's Cafe Americain
Read
Sunday, January 29, 2017 5:58 PM EDT
The U.S. has the most expensive healthcare system in the developed nations. And that is largely due to corruption and a twisting of the laws due to the influence of Big Pharma money in lawmaking and regulation.
17 Managed Funds That Have Beaten The Indexes Over A 17 Year Period
Article By:
Tom Madell
Read
Sunday, January 29, 2017 4:36 PM EDT
Strong data goes against what the large majority of investors now seem to believe: that index funds are a consistently better choice than managed mutual funds.
In this article: VASVX, VDIGX, VEIPX, VEXPX, VGENX, VGHCX, VGPMX, VGTSX, VHCOX, VHGEX, VINEX, VMGRX, VMRGX, VPMCX, VQNPX, VSEQX, VTRIX, VTSMX, VWIGX, VWNDX, VWNFX, VWUSX
Economic Events Of The Coming Week - Sunday, Jan. 29
Article By:
Anyoption
Read
Sunday, January 29, 2017 10:00 AM EDT
On Wednesday, the Fed is scheduled to announce interest rates, and while a hike seems unlikely, it could come with some forward guidance. Major earnings this week include Pfizer and Apple (Tuesday), Facebook (Wednesday) and Amazon (Thursday).